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Abstract
Background: Microvascular endothelial barrier dysfunction is the central enigma in spotted fever group (SFG)
rickettsioses. Angiogenin (ANG) is one of the earliest identified angiogenic factors, of which some are relevant to
the phosphorylation of VE-cadherins that serve as endothelial adherens proteins. Although exogenous ANG is
known to translocate into the nucleus of growing endothelial cells (ECs) where it plays a functional role, nuclear
ANG is not detected in quiescent ECs. Besides its nuclear role, ANG is thought to play a cytoplasmic role, owing to
its RNase activity that cleaves tRNA to produce small RNAs. Recently, such tRNA-derived RNA fragments (tRFs) have
been shown to be induced under stress conditions. All these observations raise an intriguing hypothesis about a
novel cytoplasmic role of ANG, which is induced upon infection with Rickettsia and generates tRFs that may play
roles in SFG rickettsioses.
Methods: C3H/HeN mice were infected intravenously with a sublethal dose of R. conorii. At days 1, 3, and 5 post
infection (p.i.), liver, lung and brain were collected for immunofluorescence (IF) studies of R. conorii and angiogenin
(ANG). Human umbilical vein endothelial cells (HUVECs) were infected with R. conorii for 24, 48, and 72 hrs before
incubation with 1μg/ml recombinant human ANG (rANG) in normal medium for 2 hrs. HUVEC samples were
subjected to IF, exogenous ANG translocation, endothelial permeability, and immunoprecipitation phosphorylation
assays. To identify small non-coding RNAs (sncRNAs) upon rickettsial infection, RNAs from pulverized mouse lung
tissues and HUVECs were subjected to library preparation and deep sequencing analysis using an Illumina 2000
instrument. Identified sncRNAs were confirmed by Northern hybridization, and their target mRNAs were predicted
in silico using BLAST and RNA hybrid programs.
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Results: In the present study, we have demonstrated endothelial up-regulation of ANG, co-localized with SFG
rickettsial infection in vivo. We also have provided direct evidence that rickettsial infection sensitizes human ECs to
the translocation of exogenous ANG in a compartmentalized pattern at different times post-infection. Typically,
exogenous ANG translocates into the nucleus at 24 hrs and to the cytoplasm at 72 hrs post-infection. The ANG
cytoplasmic translocation enhances phosphorylation and destabilization of VE-cadherin and attenuates endothelial
barrier function. Of note, deep sequencing analysis detected tRFs, mostly derived from the 5'-halves of host tRNAs,
that are induced by ANG. Northern hybridization validates the two most abundantly cloned tRFs derived from
tRNA-ValGTG and tRNA-GlyGCC, in both mouse tissues and human cells. Bioinformatics analysis predicted that these
tRFs may interact with transcripts associated with the endothelial barrier, the host cell inflammatory response, and
autophagy.
Conclusions: Our data provide new insight into the role of compartmentalized ANG during SFG rickettsioses, and
highlight its possible mediation through tRFs.
Background
Spotted fever group (SFG) rickettsioses are of global
public health importance [1-4]. These tick-borne diseases
are caused by obligately intracellular bacteria of the genus
Rickettsia (R.) that include R. rickettsii (causative agent of
Rocky Mountain spotted fever [RMSF]) and R. conorii
(causative agent of Mediterranean spotted fever) [5,6].
Up to 20% of untreated and 5% of treated RMSF cases
result in a fatal outcome caused by systemic microvascular
hyperpermeability [2]. R. rickettsii is also designated as a
potential bioterror agent [7].
Spotted fever group rickettsiae target host endothelial
cells that line the blood vessels. Microvascular endo-
thelial barrier dysfunction is the central enigma in SFG
rickettsioses [1-4,8]. Many possibilities have been sug-
gested to explain the cause of endothelial permeability.
However, a defined mechanism has not been determined
for this phenomenon [9,10]. The endothelial barrier
includes cell–cell adhesion proteins at cell junctions.
Our recent study indicated that upon infection by SFG
rickettsiae, phosphorylation of adhesion proteins directly
attenuates homophilic protein–protein interactions at the
endothelial adherens junctions [11], but the underlying
molecular mechanism remains unclear.
Previous studies suggested that a subset of angiogenic
factors had inconsistent effects on the regulation of
endothelial barrier function [12-16]. Human angiogenin
(ANG) is one of the earliest identified angiogenic factors,
produced mainly by hepatocytes, and correlates with not
only angiogenesis but also vascular and tissue homeostasis
in the human placenta [17-19]. Endogenous ANG accumu-
lation in endothelial nuclei is a general requirement for
endothelial proliferation and angiogenesis induced by other
angiogenic factors including VEGF, FGF, and EGF [20].
Moreover, exogenously added ANG rapidly translocates
into the nucleus of growing endothelial cells, binds to
DNA, activates rRNA transcription, and promotes protein
synthesis [21-23]. Endocytosis of ANG is mediated by an
unidentified membrane receptor and can be inhibited by
neomycin [24]. The relocalization of ANG is independent
of lysosome and the microtubule system, but is strictly
dependent on endothelial cell density [21,25]. No nuclear
ANG is detected in confluent quiescent endothelial cells
[20,21]. Furthermore, ANG does not induce any detectable
cellular internalization in primary non-blood vessel cells
(including epithelial cells and fibroblasts) regardless of the
cell density, except immortalized cell lines [21,22].
Given the fact that ANG interacts with ANG-specific
binding DNA sequences in endothelial cells to exhibit a
wide range of cellular responses to other angiogenic fac-
tors including migration, proliferation, and tube formation
[18,20], we undertook to determine whether ANG is also
involved in regulating endothelial barrier stability. Fur-
thermore, we sought to determine whether the endo-
cytosis of ANG can be activated if confluent endothelial
cells are infected with SFG rickettsiae, inducing bioactivity
to regulate endothelial permeability. This would be the first
study to address this issue.
Recent studies on biological activity of ANG have
extended their function from enabling cell growth and
proliferation to sustaining endothelial cell survival under
various stresses including heat shock, hypothermia, hyp-
oxia, and radiation [26-30]. These emerging roles of ANG
are distinct from those of nuclear-located ANG and are
envisioned to be relevant to cytoplasmic-localized ANG,
causing specific cleavage of tRNA, processed by its unique
capacity as a tRNA-specific ribonuclease (RNase) [18,31].
However, the referenced studies did not show concomitant
enhanced expression of ANG in cytoplasmic compartments
under these adverse conditions [18].
Besides the widely-studied microRNAs, novel types
of small non-coding RNAs (sncRNAs) have been (and are
being) discovered by virtue of recent innovations in deep
sequencing (meaning ultra-high throughput sequencing
or next generation sequencing) [32-34]. Among them,
sncRNAs derived from tRNA cleavage have gained
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significant attention recently [35-37]. Although once
regarded as junk RNA, these RNAs are generated by a
specific cleavage of mature or precursor tRNA and are
termed tRFs (tRNA-derived RNA fragments) [36]. By
definition, tRFs are precisely aligned with mature or
precursor tRNA at either end and are distinguished from
non-tRFs that are randomly mapped to anywhere in tRNA.
tRFs can be further sub-grouped into tRF-5 and -3 series
[36], depending on which end they contain.
Several groups have observed stress-induced tRNA
cleavage[26-29,38], which generates tRFs. Recently, most
tRFs were captured by deep sequencing in diverse organ-
isms ranging from yeasts to humans [29,36-40]. tRFs are
thought to be generated by a single endonuclease cleavage
of tRNA [36]. In general, tRF-5 series have been more
commonly detected than tRF-3 series. Several reports
[26,28,29] have indicated that tRF-5 series are generated
by ANG and have been characterized to have a functional
pathobiological role in several cell models [41].
ANG belongs to the RNase A superfamily and is known
as the only angiogenic protein to specifically cleave tRNA
in vivo and in vitro [29,42,43]. tRNA cleavage is speculated
to occur in the cytoplasm, especially when ANG gains ac-
cess to cytosolic tRNAs during stress [28,31]. Thus ANG’s
function in the cytoplasm is distinct from its regulation of
rRNA transcription in the nucleus [20,44]. However, there
is no direct evidence of cytoplasmic translocation of ANG
in endothelial cells triggered by adverse events [18].
Here, we hypothesize that infection with SFG R. conorii
initiates translocation of exogenous ANG into different
endothelial cellular compartments at different times post-
infection, leading to distinct functional consequences medi-
ated by cytoplasmic ANG-induced tRNA-derived sncRNAs.
In the present study, we have obtained direct evidence to
demonstrate that rickettsial infection initiates compart-
mentalized translocation of exogenous ANG in confluent
human primary endothelial cells. By investigating the
function and potential effects of this compartmentalized
translocation of ANG, we found that rickettisial infection-
triggered cytoplasmic translocation of ANG, enhanced
phosphorylation of VE-cadherin, reduced VE-cadherin
stability, and attenuated endothelial barrier function. Fur-
thermore, high throughput deep sequencing analysis and
Northern hybridization validation revealed novel tRNA-
derived sncRNAs that are predicted by in silico analysis to
interact with endothelial functions.
Methods
Ethics statement
All experiments and procedures with animals were
conducted according to the National Institutes of Health
guidelines for housing and care of laboratory animals and
performed under the protocol (IACUC 9007082), which
was reviewed and approved by the Institutional Animal
Care and Use Committee and the Institutional Biosafety
Committee at the University of Texas Medical Branch,
Galveston.
Mice
Female 8-12 week old C3H/HeN mice were purchased from
the Jackson Laboratory (Bar Harbor, ME). Experimentally
infected mice were housed in a standard CDC-approved
biosafety level 3 facility.
Reagents
Recombinant human ANG (rANG) was purchased from
R&D Systems (Minneapolis, MN). Cell culture medium
Prigrow I and fetal bovine serum were obtained from
Applied Biological Materials (Richmond, BC, Canada).
Unless otherwise indicated, all reagents were purchased
from ThermoFisher Scientific Inc (Waltham, MA).
Rickettsia purification
R. conorii (strain Malish 7) was obtained from the American
Type Culture Collection. A 10% yolk sac suspension of R.
conorii from infected embryonated chicken eggs diluted in
sucrose-phosphate-glutamate (SPG) buffer (0.218 M sucrose,
3.8 mM KH2PO4, 7.2 mM K2HPO4, 4.9 mM monosodium
L-glutamic acid, pH 7.0) was propagated through two
passages in Vero cells [11]. R. conorii were isolated using a
bead-based protocol as described previously (11). Purified
rickettsiae were frozen in SPG buffer at -80°C. Rickettial
content of the frozen stocks was determined by plaque assay
and TCID50 assays on Vero cells, and yielded approximately
1 × 109 bacterial cells per ml. Uninfected Vero cells were
processed by the same procedure as control material.
In vivo animal experiment
After dilution in PBS, a sublethal dose of R. conorii
(2×105 plaque-forming units in 200 μl per mouse) was
inoculated intravenously via the tail vein. Control
(mock infected) mice were inoculated with 200 μl of
processed uninfected Vero cells in PBS. At days 1, 3, and
5 post-infection (p.i.), liver, lung and brain were collected
and immersion fixed in methanol for 72 hours at 4°C prior
to further processing for RNA sample preparation. For
immunofluorescence (IF) studies of R. conorii and ANG,
all tissues were immersion fixed in 10% neutral-buffered
formalin for 24 hrs prior to being transferred to 70%
ethanol at 4°C until processing.
Cell culture
HUVECs (Cell application, Atlanta) were cultivated
in Prigrow I medium supplemented with 10% heat-
inactivated fetal bovine serum in 5% CO2 at 37°C. All
experiments were performed between passages 5 and
7, and cells were maintained in Prigrow I medium with
3% fetal bovine serum.
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For the ANG translocation studies and IF assays,
HUVECs were cultured on round glass coverslips (12 mm
diameter, Ted Pella, Redding, CA) until they were 90%
confluent. The cells were then infected with R. conorii at a
multiplicity of infection (MOI) of 10. After 24, 48, and 72
hrs, the cells on the coverslips were washed three times in
phosphate-buffered saline (PBS) before the downstream
studies were performed.
Immunofluorescence
Cells were fixed with cold methanol at 24, 48, or 72 hrs
post-infection. Each experiment was repeated three times.
The primary antibodies, a mouse monoclonal IgG against
ANG (1:500) (Clone 14017.7, Thermo Scientific, Rockford,
IL), a mouse monoclonal IgG against VE-cadherin (1:500)
(Clone TEA1/31, Meridian Life Science, Saco, ME), and
a rabbit polyclonal IgG antibody against SFG rickettsiae
(1:2000), were added and incubated for 2 hrs. For IF studies
on mouse tissue samples, deparaffinized and rehydrated
sections were blocked with unconjugated AffiniPure
Fab fragment goat anti-mouse IgG (H+L) (Jackson
ImmunoResearch Labs, Code Number: 115-007-003) for 1
hour at room temperature before incubation with mouse
monoclonal IgG against ANG (1:200) and rabbit polyclonal
IgG antibody against SFG rickettsiae (1:1000) over-
night at 4°C. The reactivities of antibodies to ANG and
VE-cadherin in human and mouse samples have been
confirmed by the manufacturers. ANG or VE-cadherin and
rickettsiae were detected with secondary goat anti-mouse
Alexa 488 and goat anti-rabbit Alexa 594 conjugated
antibodies (Invitrogen, Carlsbad, CA), respectively. Nucleic
were counter-stained with Prolong Gold antifade reagent
with DAPI (Invitrogen, Carlsbad, CA). A mouse monoclonal
IgG1 (Thermo Fisher Scientific, Fremont, CA) or Rabbit
Polyclonal IgG (Thermo Fisher Scientific, Fremont, CA) was
served as a negative control at same working concentration
as all above primary antibodies respectively to assure specific
staining detection. Fluorescent images were taken and
analyzed using an epifluorescence or confocal microscope.
Exogenous ANG translocation assay
HUVECs were seeded at a density of 5× 103 cells per cm2
on a coverslip and infected with R. conorii at an MOI of
10. At different times post-infection, they were washed
with serum-free medium and incubated with 1 μg/mL
rANG in medium and incubated at 37°C. Previous studies
from other groups exposed HUVECs to rANG for 1 hr,
resulting in significant nuclear translocation and increased
rRNA transcription [20,21]. In the present study, we sought
to demonstrate that ANG’s distinct compartmentalized
function correlated with its different biochemical effects
on rRNAs and tRNAs. A preliminary experiment using re-
combinant human ANG to lyse human total tRNA in vitro
revealed that a 2-hour reaction produced a significant
quantity of tRNA-derived fragments (see Additional file 1).
Therefore, we utilized a two-hour incubation at a dose of
rANG of approximately 12.5 pg per cell. Cells were washed
with PBS thrice, fixed with methanol at -20°F, and washed
again with PBS containing 30 mg/mL of bovine serum
albumin. The fixed cells were subjected to the IF procedure
as above.
Endothelial cell permeability assay
The permeability of HUVECs upon infection of R.
conorii at a MOI of 10 was determined using an in vitro
vascular permeability assay (Millipore, Billerica, MA) as
previous described [11]. Briefly, HUVECs were seeded
onto type I rat-tail collagen-coated polycarbonate Transwell
filters (6.5-mm diameter and 3-μm pore size; Millipore,
Billerica, MA), and confluent monolayers were inoculated
with R. conorii or mock-infected control Vero cell material
processed using a bead-isolating protocol. At different
times post-infection, HUVECs were exposed to ANG
(1μg/ml) or PBS for two hrs before permeability was
assessed by adding 0.5 mg/ml of fluorescein isothiocyanate
(FITC)-dextran (Sigma, St. Louis, MO) to the top chamber.
After 1 hr, FITC-dextran present in the bottom compart-
ment was assayed using a BioTek Synergy 2 multi-mode
microplate reader (485 nm excitation, 530 nm emission).
The fold-change in fluorescence intensity over the basal
permeability of monolayers was used as an indicator of
paracellular permeability of assessed monolayers. Ex-
periments were performed in replicates of four.
Immunoprecipitation (IP) phosphorylation assay
To study VE-cadherin phosphorylation, cell lysates were
prepared with an ice-cold RIPA lysis buffer (Santa Cruz
Biotechnology, Santa Cruz, CA). After centrifugation at
12,000×g for 20 min, the protein supernatant was collected.
Equal amounts of protein with optimal Dynabead Protein
G (Invitrogen, Carlsbad, CA) conjugated with anti-VE-
cadherin antibody were incubated for 2 hr at room
temperature. The Dynabead-antibody-antigen complex
pellets were precipitated and separated using DynaMag-2
(Invitrogen, Carlsbad, CA). The pellet was washed three
times with PBS, and resuspended in 20 μl of SDS sample
buffer (Invitrogen, Carlsbad, CA) and heated for 10 min at
70°C. Samples were then separated by gel electrophoresis
followed by immunoblotting. A mouse monoclonal anti-
phosphotyrosine antibody, 4G10 (Millipore, Billerica, MA)
was used at dilution of 1:500 for detection of pro-
teins containing phosphotyrosine. All experiments were
performed in replicates of three.
In vitro ANG lyse human tRNA
The 10 μl of reaction mixture contained 250 ng of purified
human total tRNA (Bio S&T, Montreal, Quebec, Canada)
and rANG (1μg/ml) in reaction buffer (30 mM HEPES pH
Gong et al. BMC Infectious Diseases 2013, 13:285 Page 4 of 16
http://www.biomedcentral.com/1471-2334/13/285
7.4, 30 mM NaCl, and 0.01% bovine serum albumin). The
reaction was performed at 37°C for the indicated times
and quenched by adding 10 μl of Gel Loading Buffer II
(Life Technologies Corp.). Cleavage products were resolved
in 15% denaturing polyacrylamide gel with 7 M urea and
visualized by ethidium bromide staining.
RNA extraction and deep sequencing
From the in vivo study, methanol fixed mouse lung
tissues were homogenized using a pulverizer (Spectrum
Laboratories, Rancho Dominiquez, CA) in an RNase-free
environment prior to the total RNA extraction procedure.
Briefly, approximately 100 mg of chopped lung tissue in
the pulverizer device were snap-frozen in liquid nitrogen
for 5 minutes prior to pulverization. Pulverized tissue
powder was blended in Trizol reagent (Invitrogen) at 4°C
for further RNA preparation. From the in vitro HUVECs
experiments, methanol fixed cells were collected at 24, 48,
or 72 hr p.i., for preparation of total cellular RNA using
Trizol reagent.
The steps involved in library preparation were (1)
size fractionation of sncRNAs from total RNA; (2) adaptor
ligation (to provide primer binding sites for subsequent
steps); (3) cDNA synthesis; (4) PCR-amplification (one
primer contained index sequences to be read during
sequencing); (5) deep sequencing analysis using an Illumina
2000 (Illuminar, San Diego, CA) for. High throughput deep
sequencing studies were performed in the Molecular
Genomics Core at UTMB.
RNA mapping and expression confirmation of tRFs by
Northern blot
After deep sequencing, a total of 70,544,933 sequence reads
was generated from mock and infected samples. After
adaptor sequence removal, sequences whose read numbers
were less than 10 were discarded. Sequences (cloned ≥ 10)
were identified by mapping to several sequence databases.
Small RNAs were mapped using Novoalign software
(Novocraft Technologies, Selangor, Malaysia) allowing two
mismatches. After initial alignment, further processing was
performed using in-house programs and SAMtools [41].
First, uniquely aligned reads and sequences aligned to more
than one genome location (ambiguously aligned reads)
were separated. The ambiguously aligned reads were then
randomly assigned to one location and combined with
uniquely aligned reads for the downstream analyses.
Northern hybridizations for sncRNAs were performed
as described [36,41], with probes shown in Figure 1A-B.
Briefly, total RNA was separated in a 15% denaturing
polyacrylamide gel with 7 M urea, and then transferred
to a positively charged nylon membrane (Amersham
Biosciences, Piscataway, NJ). The membrane was hybrid-
ized with 32P-labeled probes in ULTRAhyb-Oligo solution
(Life Technologies, Grand Island, NY), followed by washing
according to the manufacturer's instructions.
Computational prediction of target mRNAs
tRF5-ValGTG and tRF5-GlyGCC sequences were subjected
to BLAST (Basic Local Alignment Search Tool) against the
“human genome + transcript” with relaxed search pa-
rameters for initial screening. Specific parameters were:
searching “somewhat similar sequences”, word size = 16,
and expect threshold = 1000. Other parameters were auto-
matically adjusted for short input sequences. The BLAST
hits were further analyzed by using RNAhybrid. The
binding energy between tRF and target was used to make a
short list of targets whose Δ G value was <30 kcal/mol.
Statistical analysis
Values are reported as mean ± SD. The data were analyzed
using One Way ANOVA analysis (Sigmaplot, Sigma
Stat, Jandel Scientific Software, San Rafael, CA). Statistical
significance was considered as P<0.05.
Results
Upregulation of ANG in vascular endothelial cells after
SFG rickettsial infection in vivo
ANG has been found to be expressed in a wide range of
tissues, with the liver the major source for circulating
ANG in plasma [17]. ANG has been implicated in the
regulation of the cellular response to stress [18]. Upon
infection with rickettsiae, ANG was induced, as visualized
by IF (Figure 2).
Basal-level expression of ANG was detected sporadically
in mock control and day 1 p.i. of 2 × 105 plaque-forming
units (PFU) of R conorii. The ANG signal was restricted in
microvascular endothelial layers in multiple organs or
hepatocytes (green signals in images A-F in Figure 2). On
day 3 p.i., intense ANG signal was detected in vascular
endothelial layers, co-localized with rickettsial signal in
brain and rickettsial infection lesion in liver and lung
(red signals in images G-I, Figure 2). In liver, enhanced
accumulation of ANG signal was detected in endothelial
layers of hepatic sinusoid blood vessels (Figure 2H),
compared to hepatocytes. On day 5 p.i., ANG signal was
more intense and restricted in blood-brain and blood-
air barriers. Again, ANG and rickettsiae signals were
co-localized (images J-L in Figure 2). In liver, compared
to the endothelial layer of hepatic sinusoid blood vessel,
there was stronger signal of ANG in rickettsial infectious
lesions (Figure 2K).
Rickettsial infection initiated compartmentalized
translocation of exogenous ANG in endothelial cells
Accumulation of endogenous ANG in endothelial nu-
clei is a general requirement for endothelial prolifera-
tion and angiogenesis triggered by other exogenous
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Figure 1 Experimental validation of tRF expression. A and B. Sequence alignment of tRF-5s with their parental mature tRNAs. The most
abundantly cloned tRF-5 isoforms, together with their cloning numbers, are shown. For tRF5-ValGTG, our deep sequencing detected a significant
quantity of longer isoforms (designated by “tRF5-ValGTG(l)”) and a short isoform (designated by “tRF5-ValGTG(s)”), both of which were detected in
our Northern hybridization (panels shown below). In mature tRNAs, arrowheads on the top indicate cleavage sites based on the isoforms.
Anticodons are highlighted by grey. “CCA” in parenthesis indicates a CCA sequence that is post-transcriptionally added to the 3'-end of tRNA. The
lengths of each tRNA and tRF-5s are indicated in parentheses. Northern probes (used in next panels) are also aligned and shown. C-F. Northern
hybridization of each tRF-5. Photographs of an autoradiogram (designated “Northern” at the bottom) and the ethidium bromide-stained gel
(designated “EtBr” at the bottom) are shown. Molecular size markers (in nts) and identities of each band are also indicated. Northern experiments
were performed on the mouse tissues used in the deep sequencing (panels C-D) and HUVECs after indicated treatments (panels E-F).
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angiogenic factors including VEGF, FGF, and EGF [20,21].
To obtain data to support functional studies in a human
primary endothelial cell model, we determined the expres-
sion pattern of ANG in HUVECs following rickettsial in-
fection using an IF-based exogenous ANG translocation
assay [20,21].
First, infection by R. conorii induced no significant signal
of detectable endogenous ANG in endothelial cells, in
either nuclear or cytoplasmic locations (Figure 3A-D).
However, in vivo observation (Figure 2) revealed a dynamic
up-regulation of ANG in microvascular endothelial cells
following SFG rickettsial infection, displaying an organ-
specific expression pattern. Previous studies also indicated
that exogenous ANG underwent nuclear translocation
in proliferative endothelial cells [21]. However, no nuclear
ANG can be detected in confluent stable endothelial cells
[20]. We tested whether infection with SFG rickettsiae
can trigger endocytosis of exogenous ANG at 24, 48, or
72 hrs p.i.
In HUVECs exposed to ANG for 2 hours, IF studies
revealed that SFG rickettsial infection could initiate endo-
cytosis of exogenously added ANG in confluent quiescent
HUVECs (Figure 3I-L). Furthermore, R. conorii infection
initially triggered nuclear translocation of exogenous ANG
at 24 hrs p.i. Most importantly, ANG was translocated into
the cytoplasm at 48 hrs p.i. (Figure 3K) and predominated
in the cytoplasmic location at 72 hrs p.i. (Figure 3L). More-
over, neomycin, an aminoglycoside antibiotic and also an in-
hibitor that blocks nuclear translocation of human ANG
[24], caused reduced cellular internalization of human ANG
in rickettsial-infected HUVECs (Figure 3E-H). Administra-
tion of neomycin at 10 μM for 2 hrs in culture medium
Figure 2 Immunohistofluorescence studies show up-regulation of ANG in microvascular endothelial layers, co-localized with SFG
rickettsiae in lesions, in mouse brains, livers, and lungs on days 3 and 5 post-infection. Dual immunofluorescence staining of SFG
rickettsiae (red) and ANG (green) in mouse tissues using a dual wave length filter system revealed that the ANG signal was restricted to
microvascular endothelial layers in multiple organs or hepatocytes (green signals in images A-F). First appearing day 3 post-infection, compared
to mock controls, R. conorii infection (2 × 105 PFU, red signal) resulted in increased signal of ANG (green signals in image G-L) in the
microvascular endothelial layers in brain, liver and lung. Up-regulated ANG is co-localized with R. conorii (red signal) in lesions on day 5
post-infection (image J-L). Nuclei of mouse cells are counter-stained with DAPI (blue).
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before fixation did not affect the rickettsial load in endo-
thelial cells (assessed by real time PCR, data not shown).
Compartmentalized functional role of ANG on human
endothelial barrier function after infection with SFG
rickettsiae
To determine if the SFG rickettsiae-triggered endocytosis
of exogenous rANG is relevant to endothelial barrier
dysfunction, we performed in vitro assays to measure
vascular endothelial permeability. In HUVEC monolayers,
R. conorii triggered cytoplasmic translocation of exogen-
ous rANG (Figure 3L) and enhanced para-endothelial
hyperpermeability at 72 hr p.i. (Figure 4). Such augmenta-
tion could be attenuated by coadministration of neomycin
with rANG (Figure 4). This result is the first evidence
supporting the concept that SFG rickettsiae-triggered endo-
cytosis of exogenous ANG results in enhanced endothelial
permeability.
Cytoplasmic ANG enhances tyrosine phosphorylation of
VE-cadherin and VE-cadherin internalization into
endothelial cells
Our previous studies revealed that SFG rickettsiae induces
microvascular hyperpermeability via phosphorylation of
VE-cadherins [11]. IF imaging evidence from other groups
[12,45] directly demonstrated that phosphorylation of
VE-cadherins trigger internalization of VE-cadherin,
decreasing endothelial barrier function [10]. In this study,
internalized VE-cadherin was detected by immunofluores-
cent microscopy at 72 hrs p.i. (Figure 5E), compared to
mock and 24 hrs p.i. (Figure 5A-D). Addition of ANG
showed an enhancing effect on the internalization of
VE-cadherins in HUVECs at 72 hrs p.i. (Figure 5F). An
immunoprecipitation study revealed that exogenous
ANG enhanced phosphorylation of VE-cadherin at 72 hrs
p.i. (Figure 5G). There is no alteration in expression of total
VE-cadherin between control and infected experimental
monolayers at different time p.i. as detected by Western
blot assay.
Characterization of rickettsiae-triggered, ANG-induced,
tRNA-derived sncRNAs
Recently, studies on the biological activity of ANG have
been extended to sustaining endothelial cell survival in
response to stress [26-29]. Such an emerging role of ANG
correlates with its cytoplasmic localization, especially when
ANG gains access to cytosolic tRNA during stress [28,31].
ANG is an RNase which cleaves tRNA [42], as also shown
in the Additional Data file. When purified human tRNA
was incubated with human recombinant ANG (hrANG),
tRNA degradation was evident as seen by a decrease in the
intensity of mature tRNA bands and an accumulation of
smaller bands (Additional file 1).
Figure 3 SFG rickettsial infection initiated compartmentalized translocation of exogenous rANG in human primary endothelial cells.
Dual immunofluorescence staining of SFG rickettsiae (red) and ANG (green) in human umbilical vein endothelial cells (HUVECs) using a dual wave
lengths filter system revealed that there was no significant detectable endogenous ANG in endothelial cells (images A-D). R. conorii infection
triggered compartmentalized translocation of exogenous rANG at different times p.i. (images J-L). Neomycin reduced cellular internalization of
exogenous rANG in SFG rickettsiae-infected endothelial cells (images F-H). Nuclei of HUVECs are counter-stained with DAPI (blue).
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Figure 5 R. conorii infection-initiated cytoplasmic translocation of exogenous rANG enhanced VE-cadeherin internalization into endothelial
cells and tyrosine phosphorylation of VE-cadherin at 72 hrs p.i. Dual immunofluorescence staining of SFG rickettsiae (red) and VE-cadherin
(green) in human umbilical vein endothelial cells (HUVECs) using a dual wave length filter system revealed that internalized VE-cadherin could be
detected at 72 hrs p.i. (image E), compared to mock and 24 hrs p.i. (image A, C). Addition of rANG shows an enhancing effect on the internalization of
VE-cadherins in HUVECs at 72 hrs p.i. (image F). A representative immunoprecipitation (IP) study suggested that exogenous rANG enhances
phosphorylation of VE-cadherin (p-VE-cadherin) at 72 hrs p.i. (image G). Nuclei of HUVECs are counter-stained with DAPI (blue).
Figure 4 conorii infection-initiated cytoplasmic translocation of exogenous rANG and enhanced para-endothelial hyperpermeability at
72 hrs p.i., this effect can be attenuated by co-administration of neomycin with rANG. Endothelial cells were seeded on type I rat-tail
collagen-coated polycarbonate transwell filters and infected with R. conorii at an MOI of 10 in triplicate, or mock infected. After 24 and 72 hr,
HUVECs were exposed to ANG or co-administration of neomycin with ANG for two hrs. FITC-dextran was added to the upper chamber medium,
and the presence of FITC dextran in the lower chamber was quantified after 1 hr. The results are expressed as the fold-increase in monolayer
permeability over basal permeability levels (* P< 0.05). Experiments were performed in replicates of four.
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Next, we determined whether the cytoplasmic ANG
generated tRFs in vivo, by using deep sequencing. We
obtained a total read of 70,544,933 from three expe-
rimental sets, each of which was replicated 3 times
(Table 1). As expected, the most abundant class of
sncRNAs was microRNAs that occupied approximately
60% of total reads, indicating that the RNA quality was
preserved during the RNA isolation from mouse tissues.
A similar fraction of microRNAs were cloned in previ-
ous deep sequencing experiments [36,41]. If non-specific
RNA degradation occurred, the portion of microRNAs
would have been much lower.
tRFs, especially the tRF-5 series, are the second most
abundant after microRNAs (Table 1). As described above,
tRF-5 series are the 5'-side product derived from ANG
cleavage. tRF-5’s domination (>90%) over tRF-3 and
non-tRFs provided another piece of evidence that tRFs
were not intermediates of random tRNA degradation.
Most importantly, tRF-5s were significantly increased
upon rickettsial infection (Figure 6A). For comparison,
tRF-3s were barely captured and exhibited comparable
cloning frequencies between mock- and rickettsiae-infected
samples (Figure 6B). These data are in agreement with the
re-localization of ANG into the endothelial cytoplasm upon
SFG rickettsial infection.
Furthermore, we examined which particular tRF se-
quences were cloned in the deep sequencing. Based on
read numbers, the five most abundantly cloned tRFs
were sorted and tabulated in Table 2. Comparison of rela-
tive cloning frequencies (a tRF’s read number normalized
to the sample’s read number) indicated that all of them
were increased upon rickettsial infection. We chose the
two most abundantly cloned tRFs for further inspection
and experimental confirmation.
As seen in Figure 1A-B, there were several tRF isoforms
that were of an identical 5'-end but of different 3'-ends. The
Figure 6 ANG cleaves tRNA to generate tRF-5 series. A and B. Fraction of tRF-5 (panel A) and tRF-3 (panel B) in the total small RNA
population from mouse lungs. A relative cloning frequency of each tRF-5 (or -3) was calculated by normalizing the tRF’s read number to the total
read number (as shown in Table 1). The normalized values are expressed in percentages. An average and a standard deviation were calculated
from triplicate samples of each treatment.
Table 1 Summary of high-throughput sequencing data
Mock Rickettsia infection day 1 Rickettsia infection day 3
Replicate 1 Replicate 2 Replicate 3 Replicate 1 Replicate 2 Replicate 3 Replicate 1 Replicate 2 Replicate 3
Total reads 7,976,072 7,579,606 7,072,909 9,086,972 9,303,189 8,233,584 7,000,534 7,478,639 6,813,408
Mouse genome 6,825,993 6,504,196 6,142,393 7,888,232 8,053,081 7,064,456 6,014,752 6,419,927 5,653,699
(GRCm38/mm10)
Mouse small RNAs microRNA 4,726,255 4,538,273 4,437,811 5,678,975 5,617,614 4,833,244 4,099,680 4,176,360 2,843,170
piRNA 36,579 39,855 34,899 45,506 40,654 35,252 35,230 36,925 30,880
snoRNA 104,905 111,394 111,173 107,850 160,003 130,500 142,705 126,827 108,898
snRNA 11,381 12,387 11,513 11,055 14,467 12,857 18,941 19,080 15,470
rRNA 19,666 24,792 28,487 25,276 26,243 28,507 28,403 25,919 29,887
tRNA 388,179 239,575 150,429 278,754 457,630 452,977 337,384 597,214 700,422
tRNA matches tRF-5 362,050 212,503 122,029 249,710 423,795 420,596 304,148 548,458 647,353
t-RF-3 319 302 579 511 487 580 427 553 571
non-tRF 25,810 26,770 27,821 28,524 33,384 31,801 32,809 48,203 52,498
The read numbers are summarized and tabulated. Sequences matching tRNAs were further sorted into tRF-5, -3, and non-tRFs, as defined in the text. Mouse
genome (GRCm38/mm10) indicates Mus musculus genome assembled by the Genome Reference Consortium (GRCm38), UCSC version 10.
Gong et al. BMC Infectious Diseases 2013, 13:285 Page 10 of 16
http://www.biomedcentral.com/1471-2334/13/285
major isoforms were 32-34 nts long (for tRF5-ValGTG)
and 30-32 nts long (for tRF5-GlyGGY). ANG cleavage
sites, estimated from the 3'-ends of the tRF isoforms, were
located at the immediate 5’-side of the anticodon. Interest-
ingly, we also captured smaller tRF5-ValGTG of 23 nts
(Figure 1A). We designated it as “tRF5-ValGTG(s)” to
distinguish from the major tRFs of 32-34 nts which were
designated as “tRF5-ValGTG(l)”. It should be noted
that some previous studies detected tRF-5s of 30-35
nts [26,27,38], while other previous studies detected tRFs
of ~22 nts [32,37].
The expression of tRFs was confirmed by a conventional
technique. We chose Northern hybridization as the most
suitable method to confirm a tRF, because this assay visual-
izes a discrete band for the presence of a specific tRF. We
detected tRF5-ValGTG(l) (Figure 1C) and tRF5-GlyGGY(l)
(Figure 1D) at sizes consistent with our deep sequencing
data, as well as their mature tRNAs at ~75 nts. Also,
tRF5-ValGTG(s) was clearly visible at ~23 nts (Figure 1C).
All these bands were prominent and discrete along each
lane (Figure 1C-D), reinforcing that tRFs were specific
cleavage products. The expression level of tRFs appeared
to be very abundant, especially when their band intensities
were compared to those of highly abundant mature tRNA.
Most importantly, the expression of tRFs was elevated
upon infection by rickettsiae.
The data presented above were from mouse tissues.
We next questioned if the tRNA cleavage is also seen in
human cells. Sequence comparisons revealed that these
two tRFs are conserved between mice and humans. Indeed,
we could also detect these two tRFs in human endothe-
lial cells (Figure 1E-F). tRFs were barely detected in
mock-infected HUVECs (lane 4 in each panel), but became
evident after the cells were infected with SFG rickettsiae
(lane 3 in each panel). The tRF bands were pronounced
after treating with exogenous rANG in addition to infection
of the cells with SFG rickettsiae (lanes 1-2 in each panel).
Collectively, our data demonstrate tRNA cleavage by
ANG in both mouse and human cells infected with
SFG rickettsiae.
Recent studies have indicated that some tRFs regulate
their target mRNAs, like microRNAs [37]. Several studies
suggested that a subset of tRFs share a similar mechanism
to microRNA that recognize complementary sites in the
3'-untranslated regions of target mRNAs and repress gene
expression, while another subset of them have a different
mechanism [36,41]. For example, a 31-nts long tRF-5 has
been shown to inhibit target mRNA provided with a com-
plementary target site [29]; however, this trans-silencing
activity appeared to be distinct from that of microRNAs.
tRFs of our interest were 30-34 nts long (Figure 1A-B),
and significantly longer than an average microRNA size.
Thus, we reasoned that our tRFs will also act differently
from microRNAs but similarly to the 31-nts long tRF-5.
To find potential targets, we searched for mRNAs with a
sequence homologous to tRF5-ValGTG and tRF5-GlyGCC
by using the BLAST algorithm. We did not use well-
established tools for microRNA target prediction, because
they give too much weight to the first eight nucleotides of
a sncRNA (called the “seed sequence”). As aforemen-
tioned, our tRFs[36,41] are not thought to act through a
microRNA mechanism. The BLAST outputs were further
subjected to the RNAhybrid program (http://bibiserv.
techfak.uni-bielefeld.de/rnahybrid/) to evaluate their
base-pairing interaction with tRF-5. Based on Δ G values,
interactors of significant stability (-30 kcal/mol as a cutoff)
were selected and tabulated in Table 3. Among them,
PRKCB, SH3GLB1, and SNTB1 were of particular inter-
est because they were determined to be relevant to di-
verse cellular signaling pathways, including endothelial
cell proliferation and barrier function, nitric oxide syn-
thase (iNOS and eNOS), and regulation of autophagy
and apoptosis [46-48].
Discussion and conclusions
A major clinical hallmark of SFG rickettsial disease is
the infection of ECs leading to enhanced vascular per-
meability [8]. In the present study using a HUVEC
model, we confirmed previous observations from dif-
ferent in vitro endothelial cell models [49-51] that
Table 2 The most abundantly cloned tRF-5s.
Sequence Parental Relative cloning frequency (‰)
Mock Ricketsia infection
day 1 day 3
tRF5-ValGTG GTTTCCGTAGTGTAGTGGTTATCACGTTCGCCT* tRNA-Val GTG, tRNA Val GTY 3.984 6.494 12.950
tRF5-GlyGCC GCATTGGTGGTTCAGTGGTAGAATTCTCGC* tRNA-Gly-GYY, tRNA-Gly-GGG 4.767 5.734 7.638
tRF5-GlyGCC (A to C) GCCTTGGTGGTTCAGTGGTAGAATTCTCGC tRNA-Gly-GYY, tRNA-Gly-GGG 2.977 3.954 4.791
tRF5-GluCTC TCCCTGGTGGTCTAGTGGTTAGGATTCGGC tRNA-Glu-GAG 0.700 0.501 1.108
tRF5-LysCTT TCCCTGGTGGTCTAGTGGTTAGGATTCGGC tRNA-Lys-AAG 0.429 0.577 1.144
For individual tRF-5 sequences, their relative cloning frequencies were calculated as described in the Figure 6 legend. Based on the value (expressed in ‰ [1 per
1,000]), the most abundantly cloned tRF-5s were selected and tabulated. Among the five tRF-5s, two (tRF5-ValGTG and tRF5-GlyGCC: highlighted by asterisks in
their sequences) were chosen for further study. “tRF5-GlyGCC (A to C)” has been assigned as a tRF-5, because we failed to find its identical sequence in any
database and it mapped to tRF5-GlyGCC perfectly, except that the third nucleotide was C while the correct one in the mouse genome database is A.
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endothelial permeability was enhanced upon infection
endothelial cells with SFG R. conorii. However, the cel-
lular and molecular mechanisms by which SFG rickett-
siae increase endothelial permeability remain to be
elucidated. Our previous investigation [11] demon-
strated that tyrosine phosphorylation of endothelial
adherens junctional protein VE-cadherins involved
alterations in calcium-dependent homophilic protein-
protein adhesion forces between VE-cadherins on
adjacent cells, underlying endothelial paracellular dys-
function following SFG rickettsial infection. Therefore,
phosphorylation of transmembrane adhesion proteins
may serve as a pivotal regulator in endothelial barrier
dysfunction[11]. Yet the implied direct association and
the pathway to link SFG rickettsial infection of the
endothelium and VE-cadherin phosphorylation remain
unproven.
There are many mechanisms that regulate VE-
cadherin stability at adherens junctions through
modulating phosphorylation that effectively control VE-
cadherin availability at the endothelial surface [10,15].
Angiogenic stimuli such as vascular endothelial growth
factor (VEGF) [15], epidermal growth factor (EGF) [14],
fibroblast growth factor (FGF) [12], and angiopoietin-1
[16] have produced inconsistent effects on induction of
tyrosine phosphorylation of VE-cadherin. The literature
suggests that VEGF and EGF may trigger tyrosine phos-
phorylation of VE-cadherin, disassembling the adherens
junction complex through Src and Rac pathways [14,15];
angiopoietin-1 and FGF may dephosphorylate VE-cadherin
to stabilize the endothelial barrier apparatus associated
with β-integrin [12,16]. Observations from the present
study displayed that ANG, an early identified angiogenic
factor, was remarkably increased in endothelial layers in
Table 3 The predicted interactors to the two tRF-5s.
tRF Gene name [accession number] Base-paring to potential target sites ΔG value (Kcal/mol)
tRF5-ValGTG Homo sapiens protein kinase C, beta
(PRKCB), transcript variant 1, mRNA
[NM_121535.2]
-34.2
Homo sapiens carboxyl ester lipase
(bile salt-stimulated lipase) (CEL), mRNA
[NM_001807.3]
-35.3
HOMO sapiens glutamyl-tRNA synthetase 2,
mitochondrial (EARS2), transcript variant 1,
mRNA [NM_001083614.1]
-40.2
HOMO sapiens solute carrier family 23
(nucleobase trnasporters), member 2
(SLC23A2), trnascript variant 1, mRNA
[NM_005116.5]
-36.9
tRF5-GlyGCC Homo sapiens long interegenic




Homo sapiens SH3-domain GRB2-like
endophilin B1 (SH3GLB1), transcript
variant 1, mRNA [NM_016009.4]
-37.3
Homo sapiens glial cells missing
homolog 1 (drosophila) (GMC1),
mRNA [NM_016009.4]
-37.2
Homo sapiens syntrophi, beta 1
(dystrophin-asociated protein A1,
59kDa, basic component 1)
(SNTB1) mRNA [NM_021021.3
-39.7
The potential target mRNAs of the two tRF-5s and their interactions are summarized and tabulated. In the depicted base-pairing interactions, the sequences on
the top and bottom are tRF-5 and its predicted target mRNA, respectively. The numbers of target mRNAs indicate nucleotide coordinates of the RefSeq shown in
the second column. The degree of interaction, expressed in Δ G values, was calculated by the RNAhybrid program and shown.
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the microvasculature in multiple organs post-infection with
R. conorii, and co-localized with SFG rickettsiae in the le-
sion. In liver, greater accumulation of ANG located at the
endothelial layer of hepatic sinusoidal blood vessels com-
pared to hepatocytes (Figure 2H) suggest hepatocytes as
potential sources of increased synthesis of ANG after SFG
rickettsial infection, but endothelial cells are the targets of
upregulated ANG.
ANG was originally isolated from conditioned media
of human colon adenocarcinoma cells based on its an-
giogenic activity [52]. To induce a wide range of cellular
responses, ANG must undergo nuclear translocation
and enhance rRNA transcription, the rate-limiting step
of ribosome biogenesis and cell growth [21,53]. However,
in vitro studies showed that confluent quiescent endo-
thelial cells do not internalize exogenous ANG [21]. In
the present study, rickettsial infection sensitized conflu-
ent HUVECs and initiated translocation of exogenous
ANG in a compartmentalized pattern at different times
post-infection (Figure 3). Typically, at 24 hrs post-
infection, exogenous ANGs were in the nuclei. In con-
trast, at 72 hrs p.i. translocation of ANG predominated
in cytoplasm. The underlying mechanisms associated
with compartmentalized translocation during different
intervals post-infection by SFG rickettsiae still needs to
be investigated. Current evidence suggests that nuclear
translocation of ANG is via an unidentified receptor(s)
system and independent of lysosomes and the micro-
tubule system [18,25], but is strictly dependent on endo-
thelial cell density [21]. These conditions imply the
probability that suppressive signaling from confluent
quiescent endothelial cell–cell adhesion blocks endo-
cytosis of ANG, or activation of an unknown ANG-
specific transporting system by adverse environments
(e.g., stress or intracellular pathogen invasion) initiates
internalization of ANG. These two may function as an
off–on switch.
Recent studies on the biological activity of ANG have
been extended from enabling cell growth and prolifera-
tion to sustaining endothelial cell survival under adverse
conditions [26-29]. Such emerging roles of ANG are dis-
tinct from those of nuclear located ANG. Nuclear trans-
location in growing endothelial cells and malignant cells
correlates with cell proliferation through promoting
rRNA transcription and protein synthesis [20,21]. The
role of ANG under stress is envisioned to be activated in
the cytoplasm and to mediate reprogramming of global
protein translation, saving anabolic energy, and promot-
ing cell survival during adverse events [18]. Our data
directly demonstrated that SFG rickettsial infection of
endothelial cells induced dynamic translocation of ex-
ogenous ANG into different endothelial compartments
at different times post-infection. During early infection,
nuclear translocation of ANG was not associated with
functional evidence of increased endothelial permeabil-
ity. The illustrated translocation of ANG in cytoplasmic
compartments at 72 hrs p.i. (Figure 3) was concomitant
with increased endothelial permeability, which was mod-
erated by an ANG translocation inhibitor (Figure 4).
Given the facts that phosphorylation of VE-cadherin was
enhanced and endocytosis of disassembled VE-cadherin
increased when cytoplasmic translocation of exogenous
ANG took place, we conclude that, in addition to its an-
giogenic role, ANG is a key enhancing factor on endo-
thelial barrier dysfunction. The mechanism by which
SFG rickettsial infection-triggered cytoplasmic transloca-
tion of ANG results in phosphorylation of VE-cadherin
mediated endothelial barrier dysfunction has yet to be
determined.
ANG is known as the only angiogenic protein to spe-
cifically cleave tRNA in vivo and in vitro [18,42]. Al-
though ANG protein consists of 123 amino acid
residues [54], three distinct functional sites have been
identified, including a receptor-binding site, a nuclear
localization sequence, and a catalytic site executing
ribonucleolytic activity [53,55,56]. Our in vitro assay
demonstrated that ANG indeed cleaved human tRNAs
to produce tRFs. Also, our studies of mouse tissues and
HUVECs showed a clear correlation of cellular tRF-5
generation with the cytoplasmic localization of ANG,
suggesting that tRNA cleavage by ANG also occurs
in vivo when endothelial cells are infected with SFG
rickettsiae. Our data showed that the major cleavage
products were tRF-5s longer than 30 nts, and these
tRF-5s were similar in length to the previously identified
tRNA halves produced by a specific cleavage at the anti-
codon loop [26].
In addition, we detected smaller tRF-5s of ~23 nts
(for example, tRF5-ValGTG(s) in Figure 1C). These
have also been described in human cancer cell lines
[36,37]. One report showed that these are generated by
Dicer, however, we do not know if this is also the case in
the context of SFG rickettsial infection of endothelial
cells. We examined microRNA expression profiles in
our deep sequencing data, and failed to detect any glo-
bal changes upon rickettsial infection, indicating that
Dicer activity in general did not change. Also, it is not
clear whether tRF5-ValGTG(s) is generated by ANG. In
any case, these small tRF-5s were minor in quantity,
relative to the longer tRFs, which we therefore pursued
as a higher priority.
Our next study aim will be functional evaluation in
the HUVEC model. We hypothesize that tRF-5s play a
regulatory role by recognizing their target mRNAs in
base-pairing interactions. This concept has been sup-
ported by recent experimental evidence [41]. We
attempted to identify a target mRNA with functional sig-
nificance. As shown in Table 3, our computational
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predictions indicated that tRF5-ValGTG and tRF5-
GlyGCCtRFs have the potential to interact with tran-
scripts associated with endothelial barrier function, host
cell inflammatory response, and autophagy. These are
direct topics to pursue in our future studies.
There were a number of limitations in our present
study. First, use of neomycin could moderate the ability
of exogenous ANGs to enhance endothelial permeability,
yet there was elevated endothelial permeability com-
pared to SFG rickettsial infection alone (Figure 4). To
address this, future studies can include search for a spe-
cific noncellular-toxic ANG receptor inhibitor, other yet
to be indentified pathways of tRFs biogenesis, and po-
tential crosstalk between ANG-tRNA-derived sncRNAs
and other pathways.
Second, regarding tRF profiling, although several tRFs
were identified in the HUVEC model of SFG rickettsial
infection and will be the subject of our next functional
studies on HUVECs, we do not know the differences be-
tween primary human endothelial cells and endothelium
in the mouse model. While the core components of the
vertebrate microRNA pathway are highly conserved
among species, the overall scenario of tRF is not well-
understood. For long-term aims to study the functional
role of tRFs in primary human endothelial cells, deep-
sequence analysis and characterization of sncRNA in the
HUVEC model is warranted.
Third and most importantly, the mechanism that regu-
lates switching between the two distinct functional roles
of ANG, promoting rRNA transcription in the nucleus
and cleaving tRNA in the cytoplasm, is largely unexplored.
The survival of mammalian cells exposed to stress re-
quires a reprogramming of protein translation, which is
regulated by a family of eukaryotic initiation factors (elF)
[27]. Transfection of stress-induced tRFs could repress
translation of mRNAs encoding “housekeeping” proteins
and trigger the phospho-elF2α-independent stress gran-
ules that are essential components of the stress response
[27,29]. Displacement of the elF4F complex is one mech-
anism by which stress-induced tRFs reprogram protein
synthesis [29]. Data from the present study indicate that
SFG rickettsial infection of endothelial cells could induce
tRNA derived tRFs, and may protect endothelial cells
post-infection. However, subsequently triggered endothe-
lial barrier dysfunction causes secondary injury in tissues
and organs, including edema and hypoxia. The underlying
mechanisms that regulate this biopathologic outcome are
largely unknown and require further study.
Analysis of the interactions among enriched tRFs and
potential mRNA targets has provided putative mRNA can-
didates for future studies. There were three tRF-mRNA in-
teractions that attracted our immediate and high priority
attention for future studies. The first is the tRF5 inter-
action with mRNA encoding ValGTC-β protein kinase C
(PRKCB). PRKCB has been reported to be involved in sev-
eral different cellular functions, such as endothelial cell
proliferation and barrier function, B-cell activation, and in-
duction of apoptosis [47,57,58]. Potential inhibition of this
mRNA by this tRF is quite possibly relevant to the patho-
genic mechanism in SFG rickettsioses. The second is tRF5-
GlyGCC interaction with mRNA that encodes for
syntrophin. Syntrophins are adapter proteins that use mul-
tiple protein interaction domains to localize a variety of sig-
naling proteins to specific intracellular locations. These
include nitric oxide synthase (iNOS and eNOS) that is im-
portant for intracellular killing, kinases, ion channels, and
water channels [46,59,60]. This tRF5-mRNA interaction is
also a putative topic for further functional studies in regard
to immunity to and pathogenesis of SFG rickettsiae. tRF5-
GlyGCC is the third interaction with mRNA, and we iden-
tified a target which encodes for endophilin B1 ( also
known as Bax-interactin factor 1)[48]. Endophilin B1 has
been reported to be a key regulator in autophagy through
the Bcl2-associated X (Bax) protein pathway [48,61,62].
Further research into the roles of tRFs could potentially
increase our knowledge regarding the pathogenesis of
SFG rickettsiae.
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